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I.I. Galaria, S.M. Suroweic and M.G. Davies*Division of Vascular Surgery, Center for Vascular Disease, University of Rochester, Rochester, NY 14642, USAWe describe a successful coil embolization of a bleeding superior mesenteric artery pseudoaneurysm..Introduction
Pseudoaneurysms of the superior mesenteric artery
are rare; only a few reports describe such lesions and
its treatment. This case successfully describes an
endovascular treatment approach that can potentially
stabilize and treat patients with these lesions even in
the presence of active symptoms.Case Report
A 78 year male presented to an outside institution with
hypogastric pain and anemia. He has steroid depen-
dent rheumatoid arthritis, atrial fibrillation for which
he is on warfarin therapy, chronic renal insufficiency,
congestive heart failure—American Heart Association
Class II, and chronic obstructive pulmonary disease. A
screening abdominal computed tomography scan
revealed a proximal superior mesenteric artery
(SMA) pseudoaneurysm with blood within the trans-
verse mesentery (Fig. 1(A)). His condition stabilized
after he had received two units of packed red blood
cells. Forty-eight hours later he had rebled and was
transferred to our institution. An arteriogram on
arrival demonstrated a bilobular SMA pseudoaneur-
ysm (Fig. 1(B)). Selective catheterization of the SMA
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0001+ 03 q 2005 Published by Elsevier Ltd.Open access undperformed and coil embolization of the pseudoaneur-
ysm achieved (Fig. 1(C) and (D)). The initial SMA
arteriogram revealed an abnormal characteristic of the
distal mesenteric vessels suggestive of vasculitis (Fig.
1(A)). An open jejunal biopsy revealed no evidence of
vasculitis, however. The patient is doing well a year
following his procedure with no abdominal
symptoms.Discussion
The incidence of superior mesenteric artery pseudoa-
neurysms is rare, more so than the incidence of
superior mesenteric artery aneurysms which occur at
a frequency of one in 12,000 to one in 19,000 cases.
However, in recent years, the rate of diagnosis has
increased due to the rise in abdominal imaging.1,2
Pancreatitis, trauma, and vasculitis are among the
most frequent causes of these pseudoaneurysms.
Bacteria or fungi, unlike in SMA aneurysms, are not
as often found.3,4 Unlike other visceral aneurysms, 52–
90% of SMA aneurysms are symptomatic on presen-
tation.3,5 These patients classically experience vague,
intermittent abdominal pain or intermittent gastroin-
testinal bleeding. Diagnosis can be made by MRI, CT
or abdominal ultrasound, however, none of these
imaging modalities are as sensitive as mesenteric
angiography.6 Particularly, in patients with a vasculi-
tis, diagnosis may be especially difficult due to the
potentially smaller sizes of the aneurysms/EJVES Extra xx, 1–3 (xxxx)
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Fig. 1. (A) and (B) An arteriogram demonstrating a proximal superior mesenteric artery pseudoaneurysm. (C) and (D) An
arteriogram immediately following coil embolization of the pseudoaneurysm.
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other then arteriography.7
There is no definitive study that documents the
course of a visceral pseudoaneurysm; however, based
upon case series and case reports, immediate inter-
vention is recommended because of their unpredict-
able course and their relatively high rate of
complications.8 The most feared consequence is
hemorrhage which, by some estimates, occurs ulti-
mately in almost half of these patients. The mortality
rate, 12.5–37% when treatment is attempted, can reach
almost 90% without intervention.9 Traditionally, pseu-
doaneurysms were approached and treated in the
same manner as true aneurysms; they were either
excluded through open surgery or bypassed with the
placement of a stent. Nonetheless, endovascular
therapy has gained favor, and these lesions—unlike
true aneurysms—can be frequently treated with
embolization.
Three recent series of endovascular treatment of
SMA aneurysms by coil embolization have shown
technical success rates between 79 and 100% withEJVES Extra Vol xx, Month xxxxrecanalization of only 16%.8,9 Embolization is specifi-
cally favored in patients with saccular aneurysms and
in those patients with sufficient collateral blood flow.
Embolization has also been used as a stopgap measure
to stabilize a bleeding patient pending more definitive
intervention, if necessary.6,8 Patients who have a
pseudoaneurysm secondary to an inherent inflamma-
tory condition require more aggressive and extensive
embolization to ensure that potentially weak vessel
tissue adjacent to the pseudoaneurysm are preemp-
tively treated.8
Case reports within the past few years describe the
success of intravascular deployed stents in the
management of superior mesenteric artery pseudoa-
neurysms.1,10–12 However, stents canmigrate, and they
are also at risk of thrombosis particularly in patients
with vasculitis, who may be hypercoaguable.13
Further, stents can become contaminated, particularly
if placed at a site of infection. Inserting an autogenous
vein covered stent in a contaminated or potentially
contaminated site could be more effective and safer.14
The long-term success of embolization for the
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confirmed, but this case along with a few others
suggest that embolization should be the preferred
treatment option in these patients even in cases of
active bleeding. At present, the use of stents should be
reserved for a few, select patients with poor collateral
blood flow, as an example, because of its higher risk of
potential complications particularly in patients with
SMA pseudoaneurysms.References
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